CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

October 17, 2018 Providence News Team

Patients who have relapsed or failed first-line treatment for aggressive forms of B-cell non-Hodgkin lymphoma may qualify to receive a promising CAR T-cell therapy in a new clinical trial at Providence Cancer Institute:

Study: Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-NHL-006) for B-cell non-Hodgkin lymphoma

JCAR017 is an investigational CAR T-cell therapy that modifies a patient’s own T-cells to express proteins called CARs (chimeric antigen receptors), which help T-cells recognize tumor cells and go after them. A Phase I study of JCAR017 in people with aggressive forms of B-cell lymphoma found that it provided “a durable reduction or eradication of cancer,” including complete cancer eradication in just over half of the patients. Read more in Lymphoma News Today.

CAR T-cell therapy is a major research priority for the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center. Read more about JCAR017 in Immuno-Oncology News, and find out more about adoptive T-cell therapy research at Providence.

Providence is one of only two centers in the United States currently participating in this clinical trial. For more information or to enroll a patient, call our Clinical Research office at 503-215-2614. Call us early for consideration, before the patient receives a salvage therapy or stem cell transplant.

See more studies
New research studies are added frequently. Please visit our website to see all studies in all cancer types currently open at Providence Cancer Institute.

Enter content here

About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.
More Content by Providence News Team

Welcome to your journey for creating a healthier you

CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

About the Author

Previous Article

Next Article

CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

About the Author

Previous Article

Next Article

Most Recent Articles

Providence Alaska Medical Center has once again been recognized as the top health care provider in Alaska in the U.S. News & World Report 2020-21 Best Hospitals honor roll and specialty rankings.

Load up on your veggies with this avocado and bean hummus dip. This Mediterranean-style appetizer is the perfect choice as an appetizer that is ready in minutes.

A zucchini slaw is a refreshing and unique twist for this Mexican, seafood entrée fish taco recipe, which packs a wallop of flavor while also hitting all the healthy criteria.

Providence Little Company of Mary's partnership with City of Hope helps a patient reduce his commute and spend more time doing what he loves.

Providence St. Joseph Hospital in Eureka recently received designation renewal for its Level III Trauma Center

In this Live event, Providence leaders discuss COVID and the rollout of the vaccine en Espanol.

A phase II, investigator-initiated clinical trial at Providence Cancer Institute aims to improve survival for patients with triple-negative breast cancer. The trial is available only at Providence.

There is an undeniable part of human nature that makes us feel like we must tackle big challenges by ourselves. Why are we often hesitant to reach out for help when we are struggling the most?

Cardiac care team at the Providence Heart Institute at St. Joseph Hospital in Eureka hosted virtual community health forum

A world traveler who loved her hometown and Providence Little Company of Mary.

Providence's Glenda Fossum-Smith shares how one experience changed her view of the homelessness pandemic.

While visiting your loved ones, we ask you to respectfully comply with our visitor policy

We asked Anton J. Bilchik, MD, PhD, director of our gastrointestinal and hepatobiliary program at Providence Saint John’s, to explain why timely colorectal cancer screening is important.

While visiting your loved ones, we ask you to respectfully comply with our visitor policy

The Recovery Center at Providence Little Company of Mary Medical Center San Pedro plans to reach even more people seeking treatment for alcohol or drug abuse.

Providence Heart Beat is your source for program news and service updates within the Providence Health Care family. Read the spring 2021 issue now.

Providence Little Company of Mary Medical Center San Pedro expands many service lines to meet the needs of the community.

While visiting your loved ones, we ask you to respectfully comply with our visitor policy

We understand the importance of patients having access to their loved ones while receiving care at Providence hospitals. To protect the health of our patients and caregivers, and as a safety precautio

While visiting your loved ones, we ask you to respectfully comply with our visitor policy